AI assistant
Ipca Laboratories Ltd. — Capital/Financing Update 2021
Oct 29, 2021
61700_rns_2021-10-29_4bef18cb-3d86-41f2-bc99-9ab9dc3a9c02.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer

THRU ONLINE FILING
October 29, 2021
BSE Ltd. Phiroze Jeejeebhoy Towers Dalai Street Mumbai 400 023 Scrip Code - 524494
National Stock Exchange India Limited, Exchange Plaza, C-1, Block-G, Bandra Kurla Complex, Bandra -(East). Mumbai-400051. Scrip Code : IPCALAB
Sub: Re-affirmation of CRISIL rating for Company's Rs. 200 Crore (Enhanced from Rs. 50 Crore) commercial paper
This is to inform you that CRISIL has re-affirmed its rating for the Company's commercial paper programme:
| Rs. 200 Crore (Enhanced from Rs. 50 Crore) Commercial Paper |
CRISIL A1+ (Reaffirmed) | |
|---|---|---|
| ---------------------------------------------------------------- | ------------------------- | -- |
This is for your information and record.
'Thanking you
Yours faithfully For Ipca Laboratories Limited
Harish P. Kamath Corporate Counsel & Company Secretary
Ipca Laboratories Ltd.
'
125,Kandivli Industrial Estate,CIS No.328,Kandivli (West),Mumbai400067 (Maharashtra), India | T:+91 22 62105000 F:+91 22 62105005 Regd. Office: 48, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067 (Maharashtra), India | T: +91 22 6647 4444 E: [email protected] CIN: L24239MH1949PLC007837